Compare BABA & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BABA | SYK |
|---|---|---|
| Founded | 1999 | 1941 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 423.5B | 141.2B |
| IPO Year | 2014 | N/A |
| Metric | BABA | SYK |
|---|---|---|
| Price | $165.85 | $365.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 16 |
| Target Price | $188.69 | ★ $434.19 |
| AVG Volume (30 Days) | ★ 12.3M | 1.7M |
| Earning Date | 02-19-2026 | 01-29-2026 |
| Dividend Yield | 0.63% | ★ 0.97% |
| EPS Growth | ★ 51.05 | N/A |
| EPS | 7.35 | ★ 7.61 |
| Revenue | ★ $142,158,529,239.00 | $24,381,000,000.00 |
| Revenue This Year | $6.00 | $12.01 |
| Revenue Next Year | $11.11 | $8.61 |
| P/E Ratio | ★ $22.52 | $47.79 |
| Revenue Growth | 5.21 | ★ 10.95 |
| 52 Week Low | $81.82 | $329.16 |
| 52 Week High | $192.67 | $406.19 |
| Indicator | BABA | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 58.13 | 56.30 |
| Support Level | $145.27 | $350.02 |
| Resistance Level | $173.30 | $370.88 |
| Average True Range (ATR) | 4.65 | 7.15 |
| MACD | 2.37 | 1.00 |
| Stochastic Oscillator | 72.05 | 77.94 |
Alibaba is the world's largest online and mobile commerce company as measured by gross merchandise volume. It operates China's online marketplaces, including Taobao (consumer-to-consumer) and Tmall (business-to-consumer). The China retail e-commerce platform is the most valuable cash flow-generating business at Alibaba. Additional revenue sources include China wholesale e-commerce, international retail and wholesale e-commerce, local consumer services, travel services, cloud computing, digital media and entertainment, Cainiao logistics services, and other businesses.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.